GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (FRA:TE1) » Definitions » Dividend Payout Ratio

Bio-Techne (FRA:TE1) Dividend Payout Ratio : 0.19 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bio-Techne Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bio-Techne's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.19.

The historical rank and industry rank for Bio-Techne's Dividend Payout Ratio or its related term are showing as below:

FRA:TE1' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.28   Max: 0.51
Current: 0.18


During the past 13 years, the highest Dividend Payout Ratio of Bio-Techne was 0.51. The lowest was 0.16. And the median was 0.28.

FRA:TE1's Dividend Payout Ratio is ranked better than
82.86% of 140 companies
in the Biotechnology industry
Industry Median: 0.48 vs FRA:TE1: 0.18

As of today (2024-12-15), the Dividend Yield % of Bio-Techne is 0.41%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Bio-Techne was 1.55%. The lowest was 0.24%. And the median was 0.61%.

Bio-Techne's Dividends per Share for the months ended in Sep. 2024 was €0.07.

During the past 10 years, the average Dividends Per Share Growth Rate was 0.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bio-Techne was 13.90% per year. The lowest was 0.20% per year. And the median was 4.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Bio-Techne Dividend Payout Ratio Historical Data

The historical data trend for Bio-Techne's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Dividend Payout Ratio Chart

Bio-Techne Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.19 0.16 0.16 0.18

Bio-Techne Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.17 0.16 0.19

Competitive Comparison of Bio-Techne's Dividend Payout Ratio

For the Biotechnology subindustry, Bio-Techne's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Dividend Payout Ratio falls into.



Bio-Techne Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Bio-Techne's Dividend Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2024 )/ EPS without NRI (A: Jun. 2024 )
=0.297/ 1.644
=0.18

Bio-Techne's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0.072/ 0.378
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Techne (FRA:TE1) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Bio-Techne Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Techne Business Description

Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines